Table 3

ONOO-induced tubulin oxidation/nitration and its prevention by antioxidants in Caco-2 monolayers

TreatmentFraction of Tubulin NitratedFraction of Tubulin Oxidized
Vehicle00
0.1 mM ONOO 0.73  ± 0.033-a 0.70  ± 0.043-a
1 mM ONOO 0.96  ± 0.053-a 0.94  ± 0.063-a
3 mM SIN-10.67  ± 0.013-a 0.69  ± 0.033-a
5 mM SIN-10.85  ± 0.093-a 0.83  ± 0.023-a
3 mM SANP/X/XO0.71  ± 0.073-a 0.67  ± 0.013-a
5 mM SANP/X/XO0.82  ± 0.023-a 0.84  ± 0.033-a
Urate + 1 mM ONOO 0.06  ± 0.043-b 0.09  ± 0.013-b
Urate + 5 mM SIN-10.02  ± 0.013-b 0.07  ± 0.053-b
Urate + 5 mM SANP/X/XO0.09  ± 0.033-b 0.11  ± 0.063-b
l-Cysteine + 1 mM ONOO 0.05  ± 0.043-b 0.04  ± 0.023-b
l-Cysteine + 5 mM SIN-10.03  ± 0.013-b 0.02  ± 0.013-b
l-Cysteine + 5 mM SANP/X/XO0.11  ± 0.073-b 0.13  ± 0.083-b
d-Cysteine alone00
d-Cysteine + 1 mM ONOO 0.94  ± 0.033-a 0.97  ± 0.023-a
d-Cysteine + 5 mM SIN-10.88  ± 0.083-a 0.84  ± 0.123-a
d-Cysteine + 5 mM SANP/X/XO0.84  ± 0.103-a 0.83  ± 0.073-a
SOD + 5 mM SIN-10.07  ± 0.023-b 0.10  ± 0.043-b
SOD + 5 mM SANP/X/XO0.09  ± 0.053-b 0.12  ± 0.063-b
iSOD alone00
iSOD + 5 mM SIN-10.83  ± 0.093-a 0.86  ± 0.033-a
iSOD + 5 mM SANP/X/XO0.79  ± 0.023-a 0.82  ± 0.083-a

Values are mean ± S.E. Monolayers were exposed to ONOOor donors or were preincubated (30 min) with ONOO scavengers 1) l-cysteine (3 mM) and as control d-cysteine, 2) urate (0.5 mM), or 3) SOD (300 U/ml) and as control the heat-inactivated iSOD. Controls were incubated in isotonic saline/vehicle. Cells were then processed for immunoblots to assess tubulin oxidation (carbonylation) and nitration (nitrotyrosination). Oxidation or nitration was expressed as the fraction (ratio) of carbonyl or nitrotyrosine immunoreactivity (absorbance) in the treatment group divided by oxidized or nitrated tubulin standards.

  • 3-aP < .05 versus vehicle (control), l-cysteine, SOD, or urate pretreatment.

  • 3-bP < .05 versus ONOO compounds, d-cysteine, or iSOD pretreatment.